OS Therapies OSTX Chief Operating Decision Maker — Operating Income
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by OS Therapies in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about OS Therapies's chief operating decision maker — operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is OS Therapies's chief operating decision maker — operating income?
- OS Therapies (OSTX) reported chief operating decision maker — operating income of -$10.17M in Q1 2026.
- How has OS Therapies's chief operating decision maker — operating income changed year-over-year?
- OS Therapies's chief operating decision maker — operating income decreased by 103.4% year-over-year, from -$5M to -$10.17M.
- What does chief operating decision maker — operating income mean?
- Measures the profitability or loss generated by the core business segment before accounting for non-operating items, interest, and taxes. It serves as a key indicator of the operational viability of the company's clinical-stage development activities. A negative value is common for early-stage biopharmaceutical firms heavily investing in R&D.